-
Je něco špatně v tomto záznamu ?
Differential Urinary Proteomic Analysis of Endometrial Cancer
M. Kacírová, P. Bober, M. Alexovič, Z. Tomková, S. Tkáčiková, I. Talian, L. Mederová, D. Bérešová, R. Tóth, I. Andrašina, Z. Kožlejová, R. Kilík, R. Divín, J. Sabo
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
Grantová podpora
NV16-29680A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- biologické markery moč MeSH
- endometroidní karcinom moč MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádory endometria moč MeSH
- proteom * MeSH
- studie případů a kontrol MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Endometrial cancer is one of the most frequent gynecological malignancies present in more than 95 % of all uterine cancers. In spite of that, screening of such disease is not commonly performed in clinical practice due to enormous costs and relatively low sensitivity. Therefore, developing an effective screening test to diagnose endometrial cancer at early stages is of great importance for the clinical area of investigation. In this work, we applied urinary proteomics (i.e., bottom-up proteomic approach followed by nano HPLC-ESI-MS/MS) in patients with endometrial cancer, with respect to find proteins aimed for the early diagnostics and screening. According to the results, the significant semi-quantitative changes were observed in urinary proteome of treated patients. The proteins that may be pivotal in pathogenesis of endometrial cancer, like cadherin-1 (CDH1), vitronectin (VTN) and basement membrane specific-heparan sulphate proteoglycan core protein (HSPG2) were down-regulated, when compared to the control group. Ultimately, it can be stated that urinary proteomics has a potential for the searching of cancer protein biomarkers based on their altered concentration.
1st Department of Surgery Faculty of Medicine Pavol Jozef Šafárik University Košice Slovakia
Department of Biophysics 2nd Faculty of Medicine Charles University Prague Czech Republic
Faculty of Biomedical Engineering Czech Technical University Prague Kladno Czech Republic
Slovacrin Faculty of Medicine Pavol Jozef Šafárik University Košice Slovakia
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21028201
- 003
- CZ-PrNML
- 005
- 20220325111753.0
- 007
- ta
- 008
- 211105s2019 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.934375 $2 doi
- 035 __
- $a (PubMed)32118480
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Kacířová, Miroslava $7 xx0267640 $u Department of Medical and Clinical Biophysics, Faculty of Medicine, P. J. Šafárik University in Košice, Košice, Slovakia
- 245 10
- $a Differential Urinary Proteomic Analysis of Endometrial Cancer / $c M. Kacírová, P. Bober, M. Alexovič, Z. Tomková, S. Tkáčiková, I. Talian, L. Mederová, D. Bérešová, R. Tóth, I. Andrašina, Z. Kožlejová, R. Kilík, R. Divín, J. Sabo
- 504 __
- $a Literatura
- 520 9_
- $a Endometrial cancer is one of the most frequent gynecological malignancies present in more than 95 % of all uterine cancers. In spite of that, screening of such disease is not commonly performed in clinical practice due to enormous costs and relatively low sensitivity. Therefore, developing an effective screening test to diagnose endometrial cancer at early stages is of great importance for the clinical area of investigation. In this work, we applied urinary proteomics (i.e., bottom-up proteomic approach followed by nano HPLC-ESI-MS/MS) in patients with endometrial cancer, with respect to find proteins aimed for the early diagnostics and screening. According to the results, the significant semi-quantitative changes were observed in urinary proteome of treated patients. The proteins that may be pivotal in pathogenesis of endometrial cancer, like cadherin-1 (CDH1), vitronectin (VTN) and basement membrane specific-heparan sulphate proteoglycan core protein (HSPG2) were down-regulated, when compared to the control group. Ultimately, it can be stated that urinary proteomics has a potential for the searching of cancer protein biomarkers based on their altered concentration.
- 650 _2
- $a biologické markery $x moč $7 D015415
- 650 _2
- $a endometroidní karcinom $x moč $7 D018269
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a nádory endometria $x moč $7 D016889
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a proteom $7 D020543
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bober, Peter $7 xx0267702 $u Department of Medical and Clinical Biophysics, Faculty of Medicine, Pavol Jozef Šafárik University, Košice, Slovakia
- 700 1_
- $a Alexovič, Michal $7 xx0267703 $u Department of Medical and Clinical Biophysics, Faculty of Medicine, Pavol Jozef Šafárik University, Košice, Slovakia
- 700 1_
- $a Tomková, Zuzana $7 xx0267706 $u Department of Medical and Clinical Biophysics, Faculty of Medicine, Pavol Jozef Šafárik University, Košice, Slovakia,
- 700 1_
- $a Tkáčiková, Soňa $7 xx0262785 $u Department of Medical and Clinical Biophysics, Faculty of Medicine, Pavol Jozef Šafárik University, Košice, Slovakia,
- 700 1_
- $a Talian, Ivan $7 xx0266365 $u Department of Medical and Clinical Biophysics, Faculty of Medicine, Pavol Jozef Šafárik University, Košice, Slovakia,
- 700 1_
- $a Mederová, Lenka $7 xx0267708 $u Department of Radiotherapy and Oncology, Faculty of Medicine, Pavol Jozef Šafárik University, East Slovakia Oncology Institute, Košice, Slovakia
- 700 1_
- $a Bérešová, Daniela $7 xx0267700 $u Department of Radiotherapy and Oncology, Faculty of Medicine, Pavol Jozef Šafárik University, East Slovakia Oncology Institute, Košice, Slovakia
- 700 1_
- $a Tóth, Róbert $7 xx0267714 $u Department of Radiotherapy and Oncology, Faculty of Medicine, Pavol Jozef Šafárik University, East Slovakia Oncology Institute, Košice, Slovakia
- 700 1_
- $a Andrašina, Igor, $d 1955- $7 xx0074369 $u Department of Radiotherapy and Oncology, Faculty of Medicine, Pavol Jozef Šafárik University, East Slovakia Oncology Institute, Košice, Slovakia
- 700 1_
- $a Kožlejová, Zuzana $7 xx0267717 $u Slovacrin, Faculty of Medicine, Pavol Jozef Šafárik University, Košice, Slovakia
- 700 1_
- $a Kilík, Róbert $7 xx0267722 $u First Department of Surgery, Faculty of Medicine, Pavol Jozef Šafárik University, Košice, Slovakia
- 700 1_
- $a Divín, Radek $7 xx0255506 $u Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno, Czech Republic $u Department of Biophysics, Second Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Sabo, Ján $7 xx0129263 $u Department of Medical and Clinical Biophysics, Faculty of Medicine, Pavol Jozef Šafárik University, Košice, Slovakia $u Department of Biophysics, Second Faculty of Medicine, Charles University, Prague, Czech Republic $u Czech Technical University in Prague, University Center for Energy Efficient Buildings, Buštěhrad, Czech Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 68, Suppl 4 (2019), s. S483-S490
- 773 0_
- $t Contemporary Czech and Slovak research on medical biophysics $g (2019), s. S483-S490 $w MED00208906
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32118480 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y p $z 0
- 990 __
- $a 20211105 $b ABA008
- 991 __
- $a 20220325111745 $b ABA008
- 999 __
- $a ok $b bmc $g 1735521 $s 1148746
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 68 $c Suppl 4 $d S483-S490 $e 20191230 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- BMC __
- $a 2019 $d S483-S490 $m Contemporary Czech and Slovak research on medical biophysics $x MED00208906
- GRA __
- $a NV16-29680A $p MZ0
- LZP __
- $b NLK118 $a Pubmed-20211105